Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care.

Poppers DM, Scherl EJ.

Inflamm Bowel Dis. 2008 Jan;14(1):106-13. Review.

PMID:
17886285
2.

Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease.

Epple HJ.

Dig Dis. 2009;27(4):555-9. doi: 10.1159/000233297. Epub 2009 Nov 4. Review.

PMID:
19897974
3.

General principles of medical therapy of inflammatory bowel disease.

Friedman S.

Gastroenterol Clin North Am. 2004 Jun;33(2):191-208, viii. Review.

PMID:
15177534
4.

Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment?

Jones JL, Loftus EV Jr.

Inflamm Bowel Dis. 2007 Oct;13(10):1299-307. Review.

PMID:
17600819
5.

The use of medications for inflammatory bowel disease during pregnancy and nursing.

Sauk J, Kane S.

Expert Opin Pharmacother. 2005 Sep;6(11):1833-9. Review.

PMID:
16144504
6.

Are we ready for top-down therapy for inflammatory bowel diseases: pro.

van der Woude CJ, Hommes DW.

Expert Rev Gastroenterol Hepatol. 2007 Dec;1(2):243-8. doi: 10.1586/17474124.1.2.243. Review.

PMID:
19072416
8.

Hepatitis C virus and inflammatory bowel disease.

Horn TL, Reynolds J, de Villiers W, Peña LR.

Dig Dis Sci. 2009 Jun;54(6):1171-7. doi: 10.1007/s10620-008-0489-2. Epub 2008 Oct 31. Review.

PMID:
18975088
9.

Optimizing conventional therapy for inflammatory bowel disease.

Schwartz M, Cohen R.

Curr Gastroenterol Rep. 2008 Dec;10(6):585-90. Review.

PMID:
19006615
10.

Pneumocystis carinii pneumonia in patients with ulcerative colitis treated with corticosteroids.

Bernstein CN, Kolodny M, Block E, Shanahan F.

Am J Gastroenterol. 1993 Apr;88(4):574-7.

PMID:
8470640
11.

Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto Group commentary.

Veereman-Wauters G, de Ridder L, Veres G, Kolacek S, Fell J, Malmborg P, Koletzko S, Dias JA, Misak Z, Rahier JF, Escher JC; ESPGHAN IBD Porto Group.

J Pediatr Gastroenterol Nutr. 2012 Jun;54(6):830-7. doi: 10.1097/MPG.0b013e31824d1438. Review.

PMID:
22584748
12.

Pneumocystis jiroveci pneumonia in inflammatory bowel disease: when should prophylaxis be considered?

Okafor PN, Nunes DP, Farraye FA.

Inflamm Bowel Dis. 2013 Jul;19(8):1764-71. doi: 10.1097/MIB.0b013e318281f562. Review.

PMID:
23615530
13.

Management of Pneumocystis pneumonia in patients with inflammatory disorders.

Roblot F.

Expert Rev Anti Infect Ther. 2005 Jun;3(3):435-44. Review.

PMID:
15954859
14.

Medical management of the pregnant patient with inflammatory bowel disease.

Steinlauf AF, Present DH.

Gastroenterol Clin North Am. 2004 Jun;33(2):361-85, xi. Review.

PMID:
15177544
15.

The basis of current and future therapy for inflammatory bowel disease.

Elson CO.

Am J Med. 1996 Jun;100(6):656-62. Review.

PMID:
8678087
16.

[Infliximab in inflammatory bowel diseases--conference summary and suggested guidelines].

Dotan I, Chowers Y, Rachmilewitz D, Chermesh I, Lavy A, Israeli E, Karban A, Schwaber MJ, Odes S, Eliakim R.

Harefuah. 2006 Nov;145(11):844-9, 860. Hebrew.

PMID:
17183961
17.

Review article: monitoring of immunomodulators in inflammatory bowel disease.

Aberra FN, Lichtenstein GR.

Aliment Pharmacol Ther. 2005 Feb 15;21(4):307-19. Review.

18.

Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: a multicenter, prospective, internet-based study.

Blumenstein I, Bock H, Weber C, Rambow A, Tacke W, Kihn R, Pfaff R, Orlemann S, Schaeffer R, Schröder O, Dignass A, Hartmann F, Stein J.

Inflamm Bowel Dis. 2008 Jan;14(1):53-60.

PMID:
17973301
19.

Pediatric inflammatory bowel diseases and the risk of lymphoma: should we revise our treatment strategies?

Cucchiara S, Escher JC, Hildebrand H, Amil-Dias J, Stronati L, Ruemmele FM.

J Pediatr Gastroenterol Nutr. 2009 Mar;48(3):257-67. Review.

PMID:
19274777
20.

Supplemental Content

Support Center